FDA Inspection 833544 — Adriano Lazzarin, M.D.
The FDA completed an inspection of Adriano Lazzarin, M.D. on Apr 25, 2013 in Milan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 25, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Milan (Italy)
Additional Details
Clinical Investigator (CI)